Back to News & Events

BARDA: Immunechip+ Program Overview

Tools that accelerate medical countermeasure screening and development are vital to improving human health – from enabling personalized medicine to responding to health security threats such as pandemics. To this end, BARDA, in partnership with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health, has launched the new ImmuneChip+ program.

We aim to partner with innovators to support the development of advanced microphysiological systems / tissue chip platforms that integrate a component of the human immune system. The objective of the program is to develop a set of set of mature ImmuneChips, combining a previously validated model of a vital human tissue (e.g. lung, heart, kidney) with an immune system component, in a single platform that can be machine-manufactured and that includes multiple in-line sensors for long-term tissue monitoring. With this program, we aim to further enhance the usability of tissue chips and position them as useful tools in the drug development process and for personalized therapeutics.

For more details, please visit BARDA DRIVe program at https://drive.hhs.gov/immunechip.html

Related Stories

WP_Query Object
(
    [query] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
        )

    [query_vars] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
            [error] => 
            [m] => 
            [p] => 0
            [post_parent] => 
            [subpost] => 
            [subpost_id] => 
            [attachment] => 
            [attachment_id] => 0
            [name] => 
            [pagename] => 
            [page_id] => 0
            [second] => 
            [minute] => 
            [hour] => 
            [day] => 0
            [monthnum] => 0
            [year] => 0
            [w] => 0
            [category_name] => 
            [tag] => 
            [cat] => 
            [tag_id] => 
            [author] => 
            [author_name] => 
            [feed] => 
            [tb] => 
            [paged] => 0
            [meta_key] => 
            [meta_value] => 
            [preview] => 
            [s] => 
            [sentence] => 
            [title] => 
            [fields] => all
            [menu_order] => 
            [embed] => 
            [category__in] => Array
                (
                )

            [category__not_in] => Array
                (
                )

            [category__and] => Array
                (
                )

            [post__in] => Array
                (
                )

            [post__not_in] => Array
                (
                )

            [post_name__in] => Array
                (
                )

            [tag__in] => Array
                (
                )

            [tag__not_in] => Array
                (
                )

            [tag__and] => Array
                (
                )

            [tag_slug__in] => Array
                (
                )

            [tag_slug__and] => Array
                (
                )

            [post_parent__in] => Array
                (
                )

            [post_parent__not_in] => Array
                (
                )

            [author__in] => Array
                (
                )

            [author__not_in] => Array
                (
                )

            [search_columns] => Array
                (
                )

            [ignore_sticky_posts] => 
            [suppress_filters] => 
            [cache_results] => 1
            [update_post_term_cache] => 1
            [update_menu_item_cache] => 
            [lazy_load_term_meta] => 1
            [update_post_meta_cache] => 1
            [nopaging] => 
            [comments_per_page] => 50
            [no_found_rows] => 
            [order] => 
        )

    [tax_query] => WP_Tax_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => AND
            [table_aliases:protected] => Array
                (
                )

            [queried_terms] => Array
                (
                )

            [primary_table] => wp_posts
            [primary_id_column] => ID
        )

    [meta_query] => WP_Meta_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => 
            [meta_table] => 
            [meta_id_column] => 
            [primary_table] => 
            [primary_id_column] => 
            [table_aliases:protected] => Array
                (
                )

            [clauses:protected] => Array
                (
                )

            [has_or_relation:protected] => 
        )

    [date_query] => 
    [request] => SELECT SQL_CALC_FOUND_ROWS  wp_posts.ID
					 FROM wp_posts 
					 WHERE 1=1  AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
					 
					 ORDER BY RAND()
					 LIMIT 0, 3
    [posts] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 5065
                    [post_author] => 4
                    [post_date] => 2026-09-01 14:03:32
                    [post_date_gmt] => 2026-09-01 18:03:32
                    [post_content] => 

Applications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the next stage of development.

BioREACH funds milestone-driven studies and welcomes biomedical innovations as well as platforms, tools, computational technologies, and other enabling technologies with the potential to contribute to solutions addressing unmet needs in health.

Application deadline: October 29, 2026, 5:00pm ET

For info sessions, eligibility and deadlines visit our REACH Website and FAQ.

The Center for Biotechnology (CfB) has helped advance some of Stony Brook University’s most impactful biomedical innovations, among them the yeast two-hybrid system, Xiaflex®, ReoPro®, Oracea®, and 3D virtual colonoscopy. The CfB has supported more than 475 faculty-led translational research projects and contributed to 306 license agreements generating $51 million in royalty returns to the University.

Questions? Reach out to our program contacts or sign up for office hours:

Dee Dao, PhD, Associate Director, dee.dao@stonybrook.edu
Office Hours: Monday–Friday, 2–3:30 PM | Sign up Here

Zelda Mendelowitz, PhD, Venture Associate, zelda.mendelowitz@stonybrook.edu
Office Hours: Tuesday, Wednesday, Friday, 8–11 AM | Sign up Here

[post_title] => BioREACH: Translational Research Funding Opportunity [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => bioreach-translational-research-funding-opportunity [to_ping] => [pinged] => [post_modified] => 2026-09-04 11:55:36 [post_modified_gmt] => 2026-09-04 15:55:36 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=5065 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 3083 [post_author] => 3 [post_date] => 2018-11-16 14:26:57 [post_date_gmt] => 2018-11-16 14:26:57 [post_content] => Update courtesy of BBC Entrepreneurial Training and Consulting NIH is strongly encouraging small businesses to contact the appropriate Institute or Center early in their application planning to ensure their technology is a priority for the Institute/Center. An updated SBIR/STTR Application Guide with additional instructions for SBIR Direct Phase II application preparation and submission will be posted by November 26, 2018. The following sections of each FOA are changed: Part 2, Section I. Funding Opportunity Description The following has been added at the end of the section for each FOA: PA-18-573 The following Components will not accept an SBIR Direct-to-Phase II submission: - National Institute of Nursing Research (NINR) - National Center for Complementary and Integrative Health (NCCIH) PA-18-574 The following Components will not accept an SBIR Direct-to-Phase II submission: - National Institute of Environmental Health Sciences (NIEHS ) - National Institute of Nursing Research (NINR) - National Center for Complementary and Integrative Health (NCCIH) - Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP) - Centers for Disease Control and Prevention (CDC) (All Components of CDC) - U.S. Food and Drug Administration (FDA) (All Components of FDA) Part 2, Section II. Award Information for both PA-18-573 and PA-18-574. Application types now allowed are: - New (Phase I, Fast-Track) - New (Direct Phase II) - Renewal (Phase II) - Resubmission (all phases) - Phase IIB Competing Renewal (Phase IIB) - Revision The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types. [post_title] => Important SBIR/STTR Information Update from NIH [post_excerpt] => An updated SBIR/STTR Application Guide with additional instructions for SBIR Direct Phase II application preparation and submission will be posted by November 26, 2018. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => important-sbirsttr-information-update-from-nih [to_ping] => [pinged] => [post_modified] => 2018-11-16 14:26:57 [post_modified_gmt] => 2018-11-16 14:26:57 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=3083 [menu_order] => 110 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 3858 [post_author] => 3 [post_date] => 2021-12-06 17:06:08 [post_date_gmt] => 2021-12-06 17:06:08 [post_content] =>

For a limited time, the Center for Biotechnology, as part of the NYS Designated Downstate SBIR/STTR Hub, is able to offer enhanced levels of support for SBIR/STTR proposal development and implementation. With support from Empire State Development, New York State companies are eligible to access services to help them learn about, develop, and execute SBIR/STTR proposals. Support during this limited time period includes:

- Access to short webinars and intensive workshops covering major federal agencies within the SBIR/STTR program
- One-on-one iterative proposal development consulting hours with SBIR experts
- Access to professional grant writing services
- Post award implementation consulting

Full details about the program can be found here: https://centerforbiotechnology.org/resources/programs/

Contact Kate Hutchinson (kate.hutchinson@stonybrook.edu) with questions.

[post_title] => Limited Time Enhanced SBIR/STTR Support [post_excerpt] => The Center for Biotechnology is offering enhanced SBIR/STTR proposal development assistance for a limited time. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => limited-time-enhanced-sbir-sttr-support [to_ping] => [pinged] => [post_modified] => 2022-08-22 13:07:28 [post_modified_gmt] => 2022-08-22 13:07:28 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=3858 [menu_order] => 29 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [3] => WP_Post Object ( [ID] => 5131 [post_author] => 4 [post_date] => 2026-10-06 15:00:52 [post_date_gmt] => 2026-10-06 19:00:52 [post_content] =>

Congratulations to CFB Innovator and Stony Brook University Professor Dr. M. Hassan Arbab on securing an award from the SUNY Technology Accelerator Fund!

The SUNY Technology Accelerator Fund (TAF) helps support critical research, such as feasibility studies, prototyping, and testing, which demonstrate that an idea or innovation has commercial potential. The goal is to accelerate time to market for these innovations and increase their market readiness for potential investors, strategic partners and customers

Dr. Arbab, an associate professor in the Department of Biomedical Engineering, has developed a handheld, portable scanner for the diagnosis and triage of burn injuries with 93 to 95 percent or better accuracy, as compared to the current rate of clinical techniques around 60 to 65 percent, greatly expanding diagnostic capabilities and improving the care provided to patients. The Center for Biotechnology has proudly supported Dr. Arbab’s research, most recently through our BioREACH Program.

Read more about Dr. Arbab’s research and the TAF award here: https://news.stonybrook.edu/university/stony-brook-receives-seed-funding-through-suny-technology-accelerator-fund/

Visit Dr. Arbab's Terahertz Biophotonics Laboratory page here: https://you.stonybrook.edu/terahertz/

[post_title] => CFB Innovator Receives Seed Funding Through SUNY Technology Accelerator Fund [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => cfb-innovator-receives-seed-funding-through-suny-technology-accelerator-fund [to_ping] => [pinged] => [post_modified] => 2026-10-06 15:00:52 [post_modified_gmt] => 2026-10-06 19:00:52 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=5131 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 4 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 5065 [post_author] => 4 [post_date] => 2026-09-01 14:03:32 [post_date_gmt] => 2026-09-01 18:03:32 [post_content] =>

Applications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the next stage of development.

BioREACH funds milestone-driven studies and welcomes biomedical innovations as well as platforms, tools, computational technologies, and other enabling technologies with the potential to contribute to solutions addressing unmet needs in health.

Application deadline: October 29, 2026, 5:00pm ET

For info sessions, eligibility and deadlines visit our REACH Website and FAQ.

The Center for Biotechnology (CfB) has helped advance some of Stony Brook University’s most impactful biomedical innovations, among them the yeast two-hybrid system, Xiaflex®, ReoPro®, Oracea®, and 3D virtual colonoscopy. The CfB has supported more than 475 faculty-led translational research projects and contributed to 306 license agreements generating $51 million in royalty returns to the University.

Questions? Reach out to our program contacts or sign up for office hours:

Dee Dao, PhD, Associate Director, dee.dao@stonybrook.edu
Office Hours: Monday–Friday, 2–3:30 PM | Sign up Here

Zelda Mendelowitz, PhD, Venture Associate, zelda.mendelowitz@stonybrook.edu
Office Hours: Tuesday, Wednesday, Friday, 8–11 AM | Sign up Here

[post_title] => BioREACH: Translational Research Funding Opportunity [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => bioreach-translational-research-funding-opportunity [to_ping] => [pinged] => [post_modified] => 2026-09-04 11:55:36 [post_modified_gmt] => 2026-09-04 15:55:36 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=5065 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 287 [max_num_pages] => 96 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => 1 [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) [query_cache_key:WP_Query:private] => )

BioREACH: Translational Research Funding Opportunity

More Information

Important SBIR/STTR Information Update from NIH

More Information

Limited Time Enhanced SBIR/STTR Support

More Information

CFB Innovator Receives Seed Funding Through SUNY Technology Accelerator Fund

More Information